Isomer Partners’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-125,000
Closed -$11.2M 22
2021
Q1
$11.2M Sell
125,000
-750,000
-86% -$82.5M 2.8% 13
2020
Q4
$87.9M Sell
875,000
-395,000
-31% -$29.5M 14.38% 1
2020
Q3
$62.1M Hold
1,270,000
14.96% 1
2020
Q2
$51.9M Hold
1,270,000
13.85% 2
2020
Q1
$19.6M Buy
1,270,000
+650,000
+105% +$13.7M 6.98% 6
2019
Q4
$14M Buy
+620,000
New +$10.2M 3.87% 7

Other funds holding CRNC

Isomer Partners's CRNC Position: Q2 2021 in Review

Isomer Partners sold out of Cerence (CRNC) in Q2 2021, closing a stake of 125,000 shares — an estimated $11.2M sold.

Isomer Partners first reported a position in CRNC in Q4 2019 and held it in 6 quarters. The position peaked at $87.9M in Q4 2020. 342 funds tracked by Wall St. Rank hold CRNC as of Q2 2021.

  • Isomer Partners reported no remaining Cerence position as of Q2 2021 after selling out during the quarter.
  • Isomer Partners sold 125,000 Cerence shares in Q2 2021, an estimated $11.2M.
  • Isomer Partners first reported a position in Cerence in Q4 2019 and held it in 6 quarters.
  • Isomer Partners's Cerence position peaked at $87.9M in Q4 2020.
  • 342 funds tracked by Wall St. Rank held Cerence as of Q2 2021.

Based on Isomer Partners's 13F filing for Q2 2021, filed 16 Aug 2021.